NCT02566057 - Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase Psychosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 10, 2014

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions

SchizophreniaSchizoaffective DisorderSchizophreniform DisorderPsychotic DisordersBipolar Disorder

Interventions

BIOLOGICAL

PGx testing guided treatment (PGT)

Genecept Assay (GeneceptTM Assay) will provide information on genotypes of genetic variants that are relevant to psychiatric drug response. The provider can use the information to decide on which psychotropic drugs to use.

Trial Locations (1)

11004

Zucker Hillside Hospital-North Shore Long Island Jewish Health System, Glen Oaks